Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine
Clin Kidney J
.
2021 Nov 22;15(3):567-568.
doi: 10.1093/ckj/sfab234.
eCollection 2022 Mar.
Authors
Fumika Tanaka
1
,
Kan Katayama
1
,
Kensuke Joh
2
,
Kayo Tsujimoto
1
,
Masahiro Yamawaki
1
,
Ryosuke Saiki
1
,
Tairo Kurita
1
,
Tomohiro Murata
1
,
Kaoru Dohi
1
Affiliations
1
Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
2
Department of Pathology, Jikei University School of Medicine, Tokyo, Japan.
PMID:
35198160
PMCID:
PMC8767873
DOI:
10.1093/ckj/sfab234
No abstract available